AdvertisementDrug Combination Slows Progression Of ALS And Could Mark 'New Era' In Treatment03:34Download AudioResumeSeptember 02, 2020Jon HamiltonfacebookEmailPatients with a fast-progressing form of ALS who got daily doses of an experimental two-drug combination called AMX0035 scored higher on a standard measure of function than patients who didn't get the drug. (Zephyr/Science Source)
